[BMIO Roster]

The Behavioral Medicine Interventions and Outcomes [BMIO] Study Section reviews behavioral and biobehavioral approaches to treatment, management and rehabilitation related to physical or cognitive impairment; study of sequelae of diseases or disorders; and biobehavioral aspects of affect, stress, pain, symptom perception, social support, individual differences, and other psychosocial traits or states associated with or generated as a response to pathology. Included are applications focused on interactions between experiential, behavioral, social, psychological, and physiological factors and conditions for cognitive and neurological impairments as well as studies examining disability due to cognitive or physical impairments and effects on daily living and social support. Rehabilitation research includes studies of conditions associated with disability, including diseases, disorders or injuries that are associated with potentially chronic impairments [excluding time-limited reversible conditions]. Behavioral, pharmacological and device intervention studies are included if they are designed specifically to investigate relationships between basic psychosocial or biobehavioral variables and biological bases of disease. Research applications may involve use of animal models of specific disorders.

Specific areas covered by BMIO:

• Cognitive, psychological, social, and cultural factors affecting the experience and interpretation of pain or physical symptoms and their relationship to diagnosis, expression, or treatment of somatic diseases or conditions
  
  
• Psychological, behavioral or biological responses to interventions designed to reduce stress, distress or pain, or the study of reparative processes involved in somatic diseases or conditions
  
  
• Biobehavioral responses to neuroendocrine or immune factors. Any aspects of behavioral interactions with neuroendocrine or immune system function associated with somatic diseases or conditions
  
  
• Interactions between symptoms and health behavior change and management. Effects of pain, symptom perception, depression, anxiety, social, cultural and other factors on decision-making and compliance
  
  
• Screening and biobehavioral interventions for physical symptoms and chronic or acute pain conditions when study of mechanisms [e.g., mechanism of pathogenesis or response to treatment] is involved; includes genetic testing
  
  
• Management of chronic diseases and patient education in which psychological or social adjustments to physical disease are the predominant variables under study in relation to factors such as distress, emotional well-being, coping, cognitive appraisal, adherence, patient education, self-care, or self-management; projects in which the outcomes studied are changes in quality of life, psychosocial adjustment, or social and cultural factors; includes genetic counseling
  
  
• Behavioral interventions as primary or adjunctive treatments; studies of behavioral interventions designed to remedy or slow the progression of disease and disorder [e.g., behavior therapy for insomnia, cognitive intervention for early dementia]
  
  
• Rehabilitation of conditions associated with disability including cognitive, physical, communicative and social role functioning

BMIO has the following shared interests within the RPHB IRG:

• With Psychosocial Risk and Disease Prevention [PRDP]: Studies of consequences of interventions that primarily affect social development and studies of behavioral and social risk factors associated with somatic and cognitive diseases or disorders could be assigned to PRDP. Studies of behavioral and social factors associated with the treatment, management and rehabilitation of disabling physical or cognitive conditions could be assigned to BMIO.

BMIO has the following shared interests outside the RPHB IRG:

• With the Health of the Population [HOP] IRG: Studies that examine the interaction of biobehavioral and socio-environmental factors with regard to the etiology, course, prevalence, or consequences of health disorders and diseases could be assigned to the HOP IRG. Studies of interventions operating primarily through institutional, community, or policy change could also be assigned to the HOP IRG, as could studies that directly address clinical nursing practice related to the care of persons, that have an emphasis on nursing science, or that emphasize the organization of health service delivery. Applications focused on interventions to manage or recover from physical or cognitive diseases by changing the knowledge, skills, and motivation of individuals, studies closely related to development of disease management strategies, and studies of individual and situational factors that influence persons to seek rehabilitative health care could be assigned to BMIO.
  
  
• With the Biobehavioral and Behavioral Processes [BBBP] IRG: Applications focused on treatment and interventions for existing psychological disorders and disability could be assigned to the BBBP IRG. Applications focused on treatment and interventions for existing physical conditions, including pain and symptom perception and issues of compliance, could be assigned to BMIO.
  
  
• With the Oncological Sciences [ONC] IRG: Applications related to non-behavioral cancer treatment could be assigned to the ONC IRG. Applications concerned with behavioral treatments of, or rehabilitation from, cancers, including their psychological components, could be assigned to BMIO.
  
  
• With the Hematology [HEME] IRG: Applications focused on hematological diseases, including their behavioral consequences, could be assigned to the HEME IRG. Health education or training directed to the health care provider, not the patient, could also be assigned to the HEME IRG. Applications concerned with behavioral treatments of, or rehabilitation from, hematological diseases, including their psychological components, could be referred to BMIO.
  
  
• With the Cardiovascular Sciences [CVS] IRG: Applications focused on the development, physiology, and pathophysiology of the heart and circulatory systems could be assigned to the CVS IRG. Applications concerned with behavioral treatments of, or rehabilitation from, cardiovascular diseases, including psychological approaches, could be assigned to the BMIO. 
  
  
• With the Endocrinology, Metabolism, Nutrition, and Reproductive Sciences [EMNR] IRG: Applications concerned with adaptation and response at the hormonal or cellular level, those that focus on genetics, molecular biology, cellular or organ physiology and integrative biology, and applications that use methodologies focused on regulation at the cellular and molecular level could be assigned to the EMNR IRG. Applications focused on modification of individual behaviors, attitudes, psychosocial supports and resources as they affect treatment of, or rehabilitation from, obesity, diabetes, and insulin secretion and action could be assigned to BMIO.
  
  
• With the Musculoskeletal, Oral and Skin Sciences [MOSS] IRG: Applications focused on musculoskeletal, oral, or skin diseases, or their functional consequences, could be assigned to the MOSS IRG. Applications concerned with behavioral treatments of, or rehabilitation from, musculoskeletal, oral, or skin diseases, including their psychological components, could be assigned to BMIO.
  
  
• With the Digestive Sciences [DIG] IRG: Applications focused on physiological or biological processes of gastrointestinal disorders could be referred to the DIG IRG. Applications concerned with behavioral treatments of, or rehabilitation from, gastrointestinal disorders could be referred to BMIO.
  
  
• With the Respiratory Sciences [RES] IRG: Applications that address non-behavioral approaches to respiratory diseases could be assigned to the RES IRG. Applications concerned with behavioral treatments of, or rehabilitation from, respiratory diseases, including their psychological components, could be assigned to BMIO.